{"title":"FDA发布指导草案,敦促非阿片类药物治疗疼痛","authors":"Alison Knopf","doi":"10.1002/adaw.34658","DOIUrl":null,"url":null,"abstract":"<p>The Food and Drug Administration (FDA) has issued guidance designed to expand non-opioid options for chronic pain. The point is the curb misuse. This isn't a new tack for the federal government, which issued guidelines from the Centers for Disease Control and Prevention more than 10 years ago designed to curb opioid prescriptions for pain. The guidelines were, unfortunately, regarded as rules by the medical community, with the result that pain patients were suddenly denied medication (see <i>ADAW</i> https://onlinelibrary.wiley.com/doi/10.1002/adaw.32349).</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 36","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"FDA issues draft guidance urging non-opioid pain treatments\",\"authors\":\"Alison Knopf\",\"doi\":\"10.1002/adaw.34658\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The Food and Drug Administration (FDA) has issued guidance designed to expand non-opioid options for chronic pain. The point is the curb misuse. This isn't a new tack for the federal government, which issued guidelines from the Centers for Disease Control and Prevention more than 10 years ago designed to curb opioid prescriptions for pain. The guidelines were, unfortunately, regarded as rules by the medical community, with the result that pain patients were suddenly denied medication (see <i>ADAW</i> https://onlinelibrary.wiley.com/doi/10.1002/adaw.32349).</p>\",\"PeriodicalId\":100073,\"journal\":{\"name\":\"Alcoholism & Drug Abuse Weekly\",\"volume\":\"37 36\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alcoholism & Drug Abuse Weekly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34658\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcoholism & Drug Abuse Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34658","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
美国食品和药物管理局(FDA)发布了旨在扩大慢性疼痛非阿片类药物选择的指南。关键是遏制滥用。这对联邦政府来说并不是一个新策略,十多年前,美国疾病控制与预防中心(Centers for Disease Control and Prevention)发布了指导方针,旨在遏制阿片类药物治疗疼痛的处方。不幸的是,这些指导方针被医学界视为规则,结果疼痛患者突然被拒绝用药(见ADAW https://onlinelibrary.wiley.com/doi/10.1002/adaw.32349)。
FDA issues draft guidance urging non-opioid pain treatments
The Food and Drug Administration (FDA) has issued guidance designed to expand non-opioid options for chronic pain. The point is the curb misuse. This isn't a new tack for the federal government, which issued guidelines from the Centers for Disease Control and Prevention more than 10 years ago designed to curb opioid prescriptions for pain. The guidelines were, unfortunately, regarded as rules by the medical community, with the result that pain patients were suddenly denied medication (see ADAW https://onlinelibrary.wiley.com/doi/10.1002/adaw.32349).